AIR is working alongside the National Heart, Lung, and Blood Institute to develop, implement, and evaluate the National Blood Disorders Program (NBDP). The NBDP's initial focus is on sickle cell disease and the release of the first evidence-based clinical practice guidelines to manage the condition.